| ESVC – European Society of Veterinary Cardiology |
| Click here to read the speakers bio |
| Thursday 1 September |
| 09.00-09.15 |
ESVC-O-1 |
Kurogochi |
Long-term results of mitral valve repair with artificial chordae and annuloplasty in small-breed dogs |
| 09.15-09.30 |
ESVC-O-2 |
Menciotti |
Differences in mitral valve morphology between Cavalier King Charles Spaniels with mild mitral regurgitation and without mitral regurgitation. |
| 09.30-09.45 |
ESVC-O-3 |
Silva |
Analysis of pimobendan prescriptions in small breed dogs with myxomatous mitral valve disease using Electronic Health Records in Primary Care Veterinary Practices in the United Kingdom |
| 09.45-10.00 |
ESVC-O-4 |
Pires |
Routine echocardiography in healthy senior cats. How reliable are left ventricular wall measurements? |
| 10.00-10.15 |
ESVC-O-5 |
Colpitts |
Genes of inflammation and coagulation are activated in hearts from cats with hypertrophic cardiomyopathy |
| 10.15-10.30 |
ESVC-O-6 |
den Toom |
Genome wide association study of congenital pulmonic stenosis in French Bulldogs |
| 11.20-11.35 |
ESVC-O-7 |
Franchini |
Agreement between different 2-D transthoracic views and 3-D transthoracic echocardiography in identifying mitral valve prolapse in dogs |
| 11.35-11.50 |
ESVC-O-8 |
Dutton |
Aortic annular plane systolic excursion in cats with hypertrophic cardiomyopathy: 151 cases |
| 11.50-12.05 |
ESVC-O-9 |
Zoia |
An overview on the inflammatory and systemic fibrinolysis status in cats with heart disease stratified by the presence and type of congestive heart failure |
| 12.05-12.20 |
ESVC-O-10 |
Van Renterghem |
The impact of chronic right ventricular pressure overload on right and left heart morphology and function |
| 12.20-12.35 |
ESVC-O-11 |
Escalda |
Effects of angiographic contrast media on invasive pressure measurement in dogs with pulmonic stenosis undergoing balloon valvuloplasty. |
| 12.35-12.50 |
ESVC-O-12 |
Mochel |
Breakthrough: A First-In-Class Virtual Simulator for Dose Optimization Of Angiotensin Converting Enzyme Inhibitors in Cardiology |
| Friday 2 September |
| 09.45-10.00 |
ESVC-O-13 |
Langhorn |
Systemic hypocoagulability in cats with arterial thromboembolism detected by global hemostatic tests |
| 10.00-10.15 |
ESVC-O-14 |
Schreiber |
Comparison of the diagnostic value of a small, single channel, electrocardiographic monitoring patch with a standard 3-lead Holter system over 24 hours in dogs |
| 10.15-10.30 |
ESVC-O-15 |
Hezzell |
Genetic susceptibility of canine myxomatous mitral valve disease |
| 11.20-11.35 |
ESVC-O-16 |
Victorino Machado |
Left atrial fractional shortening in cats: a comparison between two echocardiographic views. |
| 11.35-11.50 |
ESVC-O-17 |
Cala |
Prevalence and clinical significance of heart murmurs in 809 cats |
| 11.50-12.05 |
ESVC-O-18 |
Puccinelli |
The Vertebral Right Heart index: a new radiographic method to assess right heart enlargement in dogs |
| 12.05-12.20 |
ESVC-O-19 |
Grosso |
Echocardiographic reference intervals for right pulmonary artery dimension and distensibility index: a prospective study in 269 healthy dogs |
| 12.20-12.35 |
ESVC-O-20 |
Mazzarella |
Feasibility of isomeric myography to measure vascular function in pet dogs |
| 12.35-12.50 |
ESVC-O-21 |
Battaia |
Atrial depolarization waves localization and characterization on surface electrocardiogram in dogs with fast supraventricular tachycardias |
| 14.25-14.40 |
ESVC-O-22 |
Oricco |
Association between echocardiographic indexes and urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) in dogs with myxomatous mitral valve disease |
| 14.40-14.55 |
ESVC-O-23 |
Olsen |
Effect of the sodium-glucose cotransporter-2 inhibitor dapagliflozin on platelet aggregation response in Cavalier King Charles Spaniels with and without cardiac disease |
| 14.55-15.10 |
ESVC-O-24 |
Olsen |
Inhibitory effect of the active pimobendan metabolite UDCG 212 on platelet aggregation in Cavalier King Charles Spaniels |
| SCH – Society of Comparative Hepatology |
| Click here to read the speakers bio |
| Thursday 1 September |
| 09.15-09.30 |
SCH-O-1 |
Nivy |
Copper-associated chronic hepatitis in Cavalier King Charles Spaniels |
| 09.30-09.45 |
SCH-O-2 |
Rodriguez-Cobos |
Clinical findings, bacteria implicated and antimicrobial resistance in 28 dogs with bacterial cholangitis in Spain: a multicentric retrospective study. |
| 09.45-10.00 |
SCH-O-3 |
Duperrier-Simond |
Prevalence and clinical relevance of cholelithiasis in cats: a multicentric retrospective study |
| 10.00-10.15 |
SCH-O-4 |
Devriendt |
Does type and amount of food influence postprandial serum bile acid concentrations in healthy dogs? |
| 10.15-10.30 |
SCH-O-5 |
Habermaass |
Serum liposoluble vitamins in canine cholestatic liver disease |
| ESVCP – European Society of Veterinary Clinical Pathology |
| Click here to read the speakers bio |
| Thursday 1 September |
| 14.25-14.40 |
ESVCP-O-1 |
Aroch |
Association between the red blood cell distribution width (rdw) at presentation in critically ill dogs and additional hematological analytes and survival |
| 14.40-14.55 |
ESVCP-O-2 |
Rompf |
Kinetics of procalcitonin plasma concentrations in dogs with bacterial sepsis |
| 14.55-15.10 |
ESVCP-O-3 |
Thalmeier |
Cat alpha-1-acid glycoprotein enzyme-linked immunosorbent assay: population-based reference values and assay performance |
| 15.25-15.40 |
ESVCP-O-5 |
Majercikova |
Diagnostic value of cerebrospinal fluid analysis in epileptic cats with negative magnetic resonance imaging or hippocampal changes only |
| 15.40-15.55 |
ESVCP-O-6 |
Henry |
Prevalence of neoplasia in dogs and cats with hypercobalaminemia: a retrospective case control study. |
| ESVNU – European Society of Veterinary Nephrology and Urology |
| Click here to read the speakers bio |
| Thursday 1 September |
| 09.00-09.15 |
ESVNU-O-1 |
Bar Nathan |
Long-term outcome of dogs recovering from acute kidney injury: 132 cases (2015-2021) |
| 09.15-09.30 |
ESVNU-O-2 |
Geddes |
Calcium-phosphate metabolism in normocalcaemic non-pedigree cats with upper urinary tract stones |
| 09.30-09.45 |
ESVNU-O-3 |
Palizzotto |
Cats with amyloid-A amyloidosis and urinalysis: proteinuria, electrophoresis and biomarker discovery |
| 09.45-10.00 |
ESVNU-O-4 |
Weinekötter |
Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratios in urothelial carcinoma in dogs |
| 10.00-10.15 |
ESVNU-O-5 |
Viitanen |
Follicular cystitis in dogs – Role of intramural E.coli bacteria |
| 10.15-10.30 |
ESVNU-O-6 |
Reyes-Hughes |
Owner’s experiences of caring for a cat with chronic kidney disease (CKD) in the United Kingdom |
| Friday 2 September |
| 09.00-09.15 |
ESVNU-O-7 |
Lippi |
Essential and non-essential serum amino acids in dogs at different stages of chronic kidney disease |
| 09.15-09.30 |
ESVNU-O-8 |
Ioannou |
Retrospective evaluation of 22 dogs with leptospirosis requiring intermittent hemodialysis (2018-2021) |
| 09.30-09.45 |
ESVNU-O-9 |
Rixon |
Neutrophil gelatinase-associated lipocalin and symmetric dimethylarginine in dogs with carcinoma or sarcoma |
| 09.45-10.00 |
ESVNU-O-10 |
Tang |
A cross-sectional study assessing macroscopic nephrocalcinosis using ultrasonography in cats with chronic kidney disease |
| 10.00-10.15 |
ESVNU-O-11 |
Chan |
Does the iodinated contrast agent administered to dogs during computed tomography imaging reduce the sensitivity of detecting a urinary tract infection? |
| 10.15-10.30 |
ESVNU-O-12 |
Cuq |
Urine gamma-glutamyl transferase to creatinine ratio in dogs undergoing contrast-enhanced computed-tomography examination – a pilot study |
| 11.20-11.35 |
ESVNU-O-13 |
Fortuna |
A retrospective analysis of risk factors for thrombotic disease in dogs with protein losing nephropathy |
| 11.35-11.50 |
ESVNU-O-14 |
Tegner |
Comparison between the glomerular filtration markers symmetric dimethylarginine and creatinine in serum from 458 cats |
| 11.50-12.05 |
ESVNU-O-15 |
Mortier |
Urinary protein: creatinine ratio and urine specific gravity in cats: cystocentesis versus home sampling |
| ESCG – European Society of Comparative Gastroenterology |
| Click here to read the speakers bio |
| Friday 2 September |
| 09.00-09.15 |
ESCG-O-1 |
Ishii |
Dogs with chronic enteropathy have increased intestinal permeability |
| 09.15-09.30 |
ESCG-O-2 |
Reisinger |
Evaluation of intestinal permeability, NetF toxin genes, sepsis and albumin in dogs with acute haemorrhagic diarrhoea syndrome |
| 09.30-09.45 |
ESCG-O-3 |
Heilmann |
Serum transcobalamin analysis in dogs – method validation and association with serum cobalamin status in dogs with chronic enteropathy |
| 09.45-10.00 |
ESCG-O-4 |
Blatt |
Hypocobalaminemia in dogs with parvovirus enteritis |
| 10.00-10.15 |
ESCG-O-5 |
Lotti |
Investigation of the relationship of mucosa-associated bacteria to clinical and histological findings in dogs with protein losing enteropathy (PLE) |
| 10.15-10.30 |
ESCG-O-6 |
Lotti |
A survey-based observational study on diagnostic and therapeutic approach to canine idiopathic protein-losing enteropathy: general practitioners’ versus gastroenterologists’ point of view |
| 11.20-11.35 |
ESCG-O-7 |
Santos |
The impact of diet reassessment in the medical management of Refractory Chronic Enteropathy in dogs- A retrospective multicentric study |
| 11.35-11.50 |
ESCG-O-8 |
Stübing |
The effect of metronidazole versus a synbiotic on selected intestinal bacteria and clinical improvement in dogs with acute diarrhoea |
| 11.50-12.05 |
ESCG-O-9 |
Cueni |
Course of disease in dogs hospitalized for acute pancreatitis – correlation of lipase activity (Roche colorimetric lipase assay, LIPC), pancreatic lipase immunoreactivity (PLI, measured as Spec PL) and clinical variables over time. |
| 12.05-12.20 |
ESCG-O-10 |
Kuzi |
The clinical course and the utility of a clinical severity scoring system and 1,2-o-dilauryl-rac-glycero glutaric acid-(6’-methylresorufin)-ester-lipase for monitoring of dogs with chronic pancreatitis |
| 12.20-12.35 |
ESCG-O-11 |
Karra |
Fecal acute phase proteins as biomarkers in cats with chronic enteropathies |
| 12.35-12.50 |
ESCG-O-12 |
Remmel |
Long-term follow-up in a cohort of 97 cats diagnosed with low-grade intestinal T-cell lymphoma or lymphoplasmacytic enteritis: clinical, biological and therapeutic features. |
| ESVIM – European Society of Veterinary Internal Medicine |
| Click here to read the speakers bio |
| Friday 2 September |
| 08.00-08.15 |
ESVIM-O-1 |
Scott-Baumann |
Metabolomic approaches highlight biochemical pathways altered in hypertensive cats |
| 08.15-08.30 |
ESVIM-O-2 |
Suciu |
Trapped Neutrophil Syndrome in Border Collies: Clinical Presentation, Diagnostic Findings, Treatment and Outcome in 10 dogs within the UK and USA |
| 08.30-08.45 |
ESVIM-O-3 |
Pichard |
Outcome and predictive factors for response to treatment of idiopathic immune-mediated polyarthritis in dogs: A retrospective study |
| 09.00-09.15 |
ESVIM-O-4 |
Snoeck |
Serum 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in dogs with sinonasal aspergillosis |
| 09.15-09.30 |
ESVIM-O-5 |
Prior |
Sinonasal Aspergillosis in dogs: a retrospective review of diagnostic findings in multiple UK referral centres (2011-2021) |
| 09.30-09.45 |
ESVIM-O-6 |
Prior |
Sinonasal Aspergillosis in dogs: a retrospective study of treatment and outcome in multiple UK referral centres (2011-2021) |
| 09.45-10.00 |
ESVIM-O-7 |
Champetier |
Nasopharyngeal stenosis in cats : a retrospective study of 21 cases comparing endoscopic and surgical treatment (2018-2022) |
| 10.00-10.15 |
ESVIM-O-8 |
Lee-Fowler |
Evaluation of thermophysiological characteristics of brachycephalic obstructive airway syndrome utilizing the combination of a cold stimulus and infrared thermography. |
| 10.15-10.30 |
ESVIM-O-9 |
Grobman |
Evaluation of Infrared Thermography and 6 Minute Walk Tests to Assess Thermoregulation and Exercise Intolerance in Dogs with Brachycephalic Obstructive Airway Syndrome |
| 11.05-11.20 |
ESVIM-O-10 |
Rizzoli |
Expression of Fibroblast Activation Protein in lungs of dogs with idiopathic pulmonary fibrosis and dogs with lung cancer |
| 11.20-11.35 |
ESVIM-O-11 |
Lyssens |
Bronchiectasis, dynamic bronchomalacia and bronchiectasis/bronchomalacia syndrome in dogs: a retrospective study |
| 11.35-11.50 |
ESVIM-O-12 |
Canonne |
Seropositivity for Aspergillus and House Dust Mites antigens in dogs with eosinophilic bronchopneumopathy |
| 11.50-12.05 |
ESVIM-O-13 |
Chan |
Prospective evaluation of the efficacy of inhaled steroids administered via the AeroDawg spacing chamber in management of dogs with chronic cough |
| 12.05-12.20 |
ESVIM-O-14 |
Hartung |
Allergy testing in cats with feline lower airway disease |
| 12.20-12.35 |
ESVIM-O-15 |
Gareis |
Correlation of radiographic and clinical parameters in cats with feline lower airway disease |
| 12.35-12.50 |
ESVIM-O-16 |
Preibisz |
Utility of ultrasound-guided fine needle aspiration of non-circumscribed pulmonary lesions in dogs and cats. |
| ISCAID - International Society for Companion Animal Infectious Diseases |
| Click here to read the speakers bio |
| Saturday 3 September |
| 08.45-09.00 |
ISCAID-O-1 |
Spiri |
Fecal Feline Coronavirus Shedding and Spike Gene Mutations in Cats with Feline Infectious Peritonitis Treated with GS-441524 |
| 09.00-09.15 |
ISCAID-O-2 |
Green |
A case series of 25 cats with effusive and non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524 |
| 09.15-09.30 |
ISCAID-O-3 |
Giselbrecht |
Prevalence of different outcomes of feline leukemia virus infection in four European countries |
| 09.30-09.45 |
ISCAID-O-4 |
Rehme |
Feline panleukopenia outbreaks and risk factors in cats in animal shelters |
| 09.45-10.00 |
ISCAID-O-5 |
Bogedale |
Presence of potential enteropathogens and their association with diarrhoea in multi-cat households |
| 10.00-10.15 |
ISCAID-O-6 |
Domingues |
Case control study into acute diarrhoea in dogs potentially caused by Providensia alcalifaciens |
| 10.15-10.30 |
ISCAID-O-7 |
Museux |
A series of 46 cases of Corynebacterium ulcerans infections in pets in France |
| 11.20-11.35 |
ISCAID-O-8 |
Bello |
Serological prevalence and criteria for selection of dogs for screening of vector borne diseases using a point-of-care test in a referral population in the United Kingdom – multicentre retrospective study (2015 – 2020) |
| 11.35-11.50 |
ISCAID-O-9 |
Jaffey |
Immunologic factors in dogs with pulmonary and disseminated coccidioidomycosis: a pilot study |
| 11.50-12.05 |
ISCAID-O-10 |
Wright |
The impact of a short, animated film on owner attitudes towards antimicrobial use in companion animals – a randomised controlled trial |
| ESVONC – European Society of Veterinary Oncology |
| Click here to read the speakers bio |
| Friday 2 September |
| 10.00-10.15 |
ESVONC-O-1 |
Marconato |
Subcutaneous mast cell tumors revisited: a prospective clinical study on 50 dogs |
| 10.15-10.30 |
ESVONC-O-2 |
Guerra |
High sensitivity and negative predictive value of methylene blue as a single technique to rule out sentinel lymph nodes: a prospective study on 25 dogs with low-grade cutaneous mast cell tumors |
| 11.20-11.35 |
ESVONC-O-3 |
Chalfon |
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinnae: a multi-institutional retrospective study |
| 11.35-11.50 |
ESVONC-O-4 |
Ubiali |
A retrospective study on bone metastasis in dogs with advanced-stage solid cancers |
| 11.50-12.05 |
ESVONC-O-5 |
Faroni |
Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy |
| 12.05-12.20 |
ESVONC-O-6 |
Agnoli |
benefit for capecitabine in dogs with biologically aggressive carcinoma of various origin: a single institution experience |
| 12.20-12.35 |
ESVONC-O-7 |
Lopes |
Transcriptomic analysis of canine B and T cell lymphoma identifies differential gene expression |
| 12.35-12.50 |
ESVONC-O-8 |
Børresen |
Experiences from the first ten canine oral cancer patients treated with FLASH radiotherapy |
| ESVE – European Society of Veterinary Endocrinology |
| Click here to read the speakers bio |
| Saturday 3 September |
| 14.25-14.40 |
ESVE-O-1 |
van den Berg |
Whole transcriptome analysis of canine pheochromocytoma and paraganglioma |
| 14.40-14.55 |
ESVE-O-2 |
Dias |
Plasma and Urinary Metanephrine and Normetanephrine in Healthy Cats – a Pilot Study |
| 14.55-15.10 |
ESVE-O-3 |
Kurtz |
Correlation between plasma renin activity determined by the traditional angiotensin I formation method and by a novel renin-angiotensin-system marker |
| 15.10-15.25 |
ESVE-O-4 |
Calvo |
Retrospective multicentre study of the medical and surgical management of feline primary hyperaldosteronism |
| 15.25-15.40 |
ESVE-O-5 |
Kurtz |
Prospective evaluation of the telmisartan suppression test as a diagnostic tool for primary hyperaldosteronism in cats |
| 15.40-15.55 |
ESVE-O-6 |
Sieber-Ruckstuhl |
Clinical features and long-term management with DOCP and prednisolone of cats with primary hypoadrenocorticism |
| 15.55-16.10 |
ESVE-O-7 |
Sanders |
Canine pituitary organoids and tumoroids as 3D in vitro model for pituitary-dependent hypercortisolism |
| 16.30-16.45 |
ESVE-O-8 |
Tardo |
Monitoring of diabetes mellitus with Flash glucose monitoring system: the owners’ point of view |
| 16.45-17.00 |
ESVE-O-9 |
Eiermann |
Accuracy of a flash glucose monitoring system for cats with diabetic ketosis or ketoacidosis |
| 17.00-17.15 |
ESVE-O-10 |
Falcone |
A mutation in the KCNJ11 gene and diabetes mellitus in the Labrador retriever |
| 17.15-17.30 |
ESVE-O-11 |
Niessen |
Once daily oral therapy for feline diabetes mellitus: SGLT-2-inhibitor velagliflozin as stand-alone therapy compared to insulin injection therapy in diabetic cats |
| 17.30-17.45 |
ESVE-O-12 |
Lombardo |
Histological investigation of the endocrine pancreas in non-diabetic cats and its relationship with pancreatitis |
| 17.45-18.00 |
ESVE-O-13 |
Thalmeier |
Assessment of the effect of inflammation on the quality of glycaemic control, insulin sensitivity and β-cell function in diabetic cats |
| ESVCN – European Society of Veterinary Comparative Nutrition |
| Click here to read the speakers bio |
| Saturday 3 September |
| 09.15-09.30 |
ESVCN-O-1 |
Carciofi |
Body composition and energy expenditure of obese dogs on weight loss programs fed diets with different amino acid profiles |
| 09.30-09.45 |
ESVCN-O-2 |
Van Vertloo |
Development of a Diet-Induced Dyslipidemia Model in Healthy Dogs Fed a Westernized Diet |
| 09.45-10.00 |
ESVCN-O-3 |
Cavalieri Carciofi |
The effect of starch to protein ratio in energy expenditure, body composition, and physical activity are different in neutered and intact, non-obese male cats |
| 10.00-10.15 |
ESVCN-O-4 |
Söder |
Effects of physical exercise in dogs and dog owners – assessed quality of life, body condition score and body mass index |
| 10.15-10.30 |
ESVCN-O-5 |
Carciofi |
Starch to protein ratio and moisture content of the food influence water balance and urine supersaturation for calcium oxalate and struvite in cats. |
